M. Docteur KEVIN LE LAY
✨ Profil synthétique
IA · 07/05/2026Le Dr Kevin Le Lay est un rhumatologue exerçant à Quincy-sous-Sénart. Ses publications sur PubMed portent sur l'économie de la santé, l'épidémiologie et les registres, ainsi que sur la qualité de vie et les mesures rapportées par les patients (PROMs).
Expertises présumées
- Évaluation de la qualité de vie
- Épidémiologie des maladies rhumatismales
- Économie de la santé en rhumatologie
- Utilisation des PROMs en rhumatologie
- Analyse de registres de santé
- Recherche en santé publique
Synthèse automatique à partir des sources publiques (HAL, OpenAlex, theses.fr, ClinicalTrials.gov, FAI²R, ANS). Pas une évaluation clinique. Le médecin peut corriger via son compte.
Diplômes
🎓 DES & spécialité ordinale
- DES Rhumatologie
- Rhumatologie (SM)
🎓 Diplômes
- DE Docteur en médecine
Source : Annuaire Santé ANS (FHIR Practitioner.qualification) · Mises à jour quotidiennes.
Localisation des cabinets
Adresses géocodées via la Base Adresse Nationale (api-adresse.data.gouv.fr). Précision indicative.
Lieux de consultation
CABINET DU DR KEVIN LE LAY
HOPITAL PRIVE CLAUDE GALIEN — 20 ROUTE DE BOUSSY SAINT ANTOINE, 91480 Quincy-sous-Sénart
Libéral© OpenStreetMapCABINET DU DR KEVIN LE LAY
CENTRE LOCOMOTEUR — 15 AVENUE DES MURS DU PARC, 94300 Vincennes
LibéralGHU APHP HM SITE HENRI MONDOR
51 Avenue MAL DE LATTRE DE TASSIGNY, 94010 Créteil
☎ 0149812111Hospitalier
%20-%202020-10-17%20-%201.jpg)
%20-%202020-10-17%20-%202.jpg)
%20-%202021-01-30%20-%201.jpg)
%20-%202021-02-10%20-%202.jpg)
Tarifs & secteur de conventionnement
Prendre rendez-vous & contact
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Top publications · les plus citées
- 1Prevalence of fibromyalgia: a survey in five European countries
Seminars in arthritis and rheumatism · 2010
📚 470 citations🎯 RCR 19.37Top 1% NIH - 2Health economic consequences related to the diagnosis of fibromyalgia syndrome
Arthritis and rheumatism · 2008
📚 100 citations🎯 RCR 4.00Top 11% NIHLire l'abstract Crossref ↓
AbstractObjectiveTo evaluate the use and costs of medical resources before and after a diagnosis of fibromyalgia syndrome (FMS) in a large primary care population in the UK.MethodsWe applied an existing data set for medical resource use among patients with a coded diagnosis of FMS. The observed quantities of 157 types of medical resource use before and after the diagnosis of FMS were multiplied by unit costs in order to calculate the cost of care (general practitioner [GP] visits, drugs, referrals, and diagnostics) within the National Health Service, excluding hospital costs. Costs before diagnosis were used in a trend analysis to predict later costs, assuming the diagnosis had never been made, and these predicted costs were compared with the observed costs after diagnosis.ResultsFollowing a diagnosis of FMS, a decrease in costs as compared with the predicted trend was observed. In the 4 years after diagnosis, the average difference between the predicted and observed cost was £66.21 per 6 months per patient. This suggests that making the diagnosis leads to savings and a decrease in resource use. The main effect was observed for tests and imaging (£24.02 per 6 months), followed by pharmaceuticals (£22.27), referrals (£15.56), and GP visits (£4.36).ConclusionFailure to diagnose a true case of FMS has its own costs, largely in excess GP visits, investigations, and prescriptions.
- 3Societal and patient burden of fibromyalgia syndrome
PharmacoEconomics · 2009
📚 75 citations🎯 RCR 3.26Top 14% NIH
Publications scientifiques (8) — classées par pathologie
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Économie santé5
▼
Économie santé5
▼- Estimates of epidemiology, mortality and disease burden associated with progressive fibrosing interstitial lung disease in France (the PROGRESS study)
Respiratory research · 2021 · Journal Article
Nasser M, Larrieu S, Boussel L, Si-Mohamed S, et al.
📚 59 cit.🎯 RCR 5.06🔬→🩺 Translationnel - Development of the Fibromyalgia Burden Assessment: measuring the multifaceted burden of fibromyalgia
Clinical and experimental rheumatology · 2010 · Journal Article
Serra E, Spaeth M, Carbonell J, Arnould B, et al.
📚 7 cit.🔬→🩺 Translationnel - Health economic evaluation of outpatient management of fibromyalgia patients and the costs avoided by diagnosing fibromyalgia in France
Clinical and experimental rheumatology · 2010 · Evaluation Study
Lamotte M, Maugars Y, Le Lay K, Taïeb C
📚 13 cit.🔬→🩺 Translationnel - Societal and patient burden of fibromyalgia syndrome
PharmacoEconomics · 2009 · Journal Article
Annemans L, Le Lay K, Taïeb C
📚 75 cit.🎯 RCR 3.26🔬→🩺 Translationnel - Health economic consequences related to the diagnosis of fibromyalgia syndrome
Arthritis and rheumatism · 2008 · Journal Article
Annemans L, Wessely S, Spaepen E, Caekelbergh K, et al.
📚 100 cit.🎯 RCR 4.00🔬→🩺 Translationnel
Épidémiologie & registres1
▼
Épidémiologie & registres1
▼- Prevalence of fibromyalgia: a survey in five European countries
Seminars in arthritis and rheumatism · 2010 · Journal Article
Branco JC, Bannwarth B, Failde I, Abello Carbonell J, et al.
📚 470 cit.🎯 RCR 19.37🔬→🩺 Translationnel
Qualité de vie / PROMs1
▼
Qualité de vie / PROMs1
▼- Linguistic validation of six patient-reported outcomes instruments into 12 languages for patients with fibromyalgia
Joint bone spine · 2010 · Journal Article
Le Gal M, Mainguy Y, Le Lay K, Nadjar A, et al.
📚 14 cit.🔬→🩺 Translationnel
Transversal1
▼
Transversal1
▼- [Evaluation of knowledge of fibromyalgia in Tunisia]
La Tunisie medicale · 2010 · English Abstract
Kamoun S, Elleuch M, Le Lay K, Feki H, et al.
📚 6 cit.🔬→🩺 Translationnel